Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Asset Utilization Ratio: 2013-2025

Historic Asset Utilization Ratio for Enanta Pharmaceuticals (ENTA) over the last 13 years, with Sep 2025 value amounting to 0.22.

  • Enanta Pharmaceuticals' Asset Utilization Ratio rose 28.74% to 0.22 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22, marking a year-over-year increase of 28.74%. This contributed to the annual value of 0.20 for FY2025, which is 23.26% up from last year.
  • Per Enanta Pharmaceuticals' latest filing, its Asset Utilization Ratio stood at 0.22 for Q3 2025, which was up 8.12% from 0.21 recorded in Q2 2025.
  • In the past 5 years, Enanta Pharmaceuticals' Asset Utilization Ratio registered a high of 0.24 during Q1 2023, and its lowest value of 0.17 during Q4 2023.
  • Over the past 3 years, Enanta Pharmaceuticals' median Asset Utilization Ratio value was 0.18 (recorded in 2024), while the average stood at 0.19.
  • Per our database at Business Quant, Enanta Pharmaceuticals' Asset Utilization Ratio crashed by 42.19% in 2021 and then grew by 28.74% in 2025.
  • Enanta Pharmaceuticals' Asset Utilization Ratio (Quarterly) stood at 0.21 in 2021, then grew by 7.40% to 0.23 in 2022, then dropped by 27.22% to 0.17 in 2023, then rose by 11.09% to 0.18 in 2024, then climbed by 28.74% to 0.22 in 2025.
  • Its Asset Utilization Ratio stands at 0.22 for Q3 2025, versus 0.21 for Q2 2025 and 0.19 for Q1 2025.